DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ rose 1.39% to $7.32 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.24% to 18,680.12 and Dow Jones Industrial Average falling 0.70% to 43,444.99.
The stock's rise snapped a three-day losing streak.
Novavax Inc. closed $16.54 short of its 52-week high ($23.86), which the company achieved on June 6th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 1.40% to $154.00, Pfizer Inc. $(PFE)$ fell 4.69% to $24.80, and Merck & Co. Inc. $(MRK)$ fell 2.08% to $96.31.
Trading volume (9.3 M) eclipsed its 50-day average volume of 6.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 15, 2024 17:29 ET (22:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。